RNA interference protects horse cells in vitro from infection with Equine Arteritis Virus

Antiviral Research

Volumn 81, Issue 3, 2009, Pages 209-216

  Heinrich, Anett ^a   Riethmüller, Diana ^a   Gloger, Marleen ^a   Schusser, Gerald F ^b   Giese, Matthias ^a   Ulbert, Sebastian ^a  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Equine Arteritis Virus; RNA interference

Indexed keywords

SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ARTERITIS; ARTICLE; CONTROLLED STUDY; DNA VIRUS; DRUG DELIVERY SYSTEM; EQUINE VIRAL ARTERITIS VIRUS; GENETIC TRANSFECTION; HORSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SYNTHESIS; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; ARTERITIS VIRUS, EQUINE; CELL LINE; HORSES; RNA INTERFERENCE; RNA VIRUS INFECTIONS; RNA, SMALL INTERFERING;

ARTERIVIRIDAE; EQUIDAE; EQUINE ARTERITIS VIRUS;

EID: 60249088348     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.10.004     Document Type: Article

References (33)

1. Bai F., Wang T., Pal U., Bao F., Gould L.H., and Fikrig E. Use of RNA interference to prevent lethal murine West Nile virus infection. J. Infect. Dis. 191 (2005) 1148-1154
2. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
3. Bryans J.T., Crowe M.E., Doll E.R., and McCollum W.H. Isolation of a filterable agent causing arteritis of horses and abortion by mares: its differentiation from the equine abortion (influenza) virus. Cornell Vet. 47 (1957) 3-41
4. Cardwell J.M., Wood J.L., Mumford J.A., Geraghty R.J., Hillyer L.L., and Pascoe R.J. Equine viral arteritis in the UK. Vet. Rec. 150 (2002) 819-820
5. Cullen B.R. Is RNA interference involved in intrinsic antiviral immunity in mammals?. Nat. Immunol. 7 (2006) 563-567
6. Das A.T., Brummelkamp T.R., Westerhout E.M., Vink M., Madiredjo M., Bernards R., and Berkhout B. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78 (2004) 2601-2605
7. de Fougerolles A., Vornlocher H.P., Maraganore J., and Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov. 6 (2007) 443-453
8. de Vries A.A., Chirnside E.D., Bredenbeek P.J., Gravestein L.A., Horzinek M.C., and Spaan W.J. All subgenomic mRNAs of equine arteritis virus contain a common leader sequence. Nucleic Acids Res. 18 (1990) 3241-3247
9. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
10. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
11. Geiss B.J., Pierson T.C., and Diamond M.S. Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA. Virol. J. 28 (2005) 53
12. Giese M., Bahr U., Jakob N.J., Kehm R., Handermann M., Müller H., Vahlenkamp T.H., Spiess C., Schneider T.H., Schusser G., and Darai G. Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus. Virus Genes 25 (2002) 159-167
13. Haasnoot J., Westerhout E.M., and Berkhout B. RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 25 (2007) 1435-1443
14. He Y.X., Hua R.H., Zhou Y.J., Qiu H.J., and Tong G.Z. Interference of porcine reproductive and respiratory syndrome virus replication on MARC-145 cells using DNA-based short interfering RNAs. Antiviral Res. 74 (2007) 83-91
15. Huang J., Jiang P., Li Y., Xu J., Jiang W., and Wang X. Inhibition of porcine reproductive and respiratory syndrome virus replication by short hairpin RNA in MARC-145 cells. Vet. Microbiol. 115 (2006) 302-310
16. Kinney R.M., Huang C.Y., Rose B.C., Kroeker A.D., Dreher T.W., Iversen P.L., and Stein D.A. Inhibition of dengue virus serotypes 1 to 4 in Vero cell cultures with morpholino oligomers. J. Virol. 79 (2005) 5116-5128
17. Kumar P., Lee S.K., Shankar P., and Manjunath N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med. 3 (2006) e96
18. Kuo L.L., Harty J.T., Erickson L., Palmer G.A., and Plagemann P.G. A nested set of eight RNAs is formed in macrophages infected with lactate dehydrogenase-elevating virus. J. Virol. 65 (1991) 5118-5123
19. Li G., Huang J., Jiang P., Li Y., Jiang W., and Wang X. Suppression of porcine reproductive and respiratory syndrome virus replication in MARC-145 cells by shRNA targeting ORF1 region. Virus Genes 35 (2007) 673-679
20. Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., Xu J., Liu Y., Zheng B.J., Woodle M.C., Zhong N., and Lu P.Y. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 11 (2005) 944-951
21. Pasternak A.O., Spaan W.J., and Snijder E.J. Nidovirus transcription: how to make sense...?. J. Gen. Virol. 87 (2006) 1403-1421
22. Posthuma C.C., Pedersen K.W., Lu Z., Joosten R.G., Roos N., Zevenhoven-Dobbe J.C., and Snijder E.J. Formation of the arterivirus replication/transcription complex: a key role for nonstructural protein 3 in the remodeling of intracellular membranes. J. Virol. 82 (2008) 4480-4491
23. Reed L.J., and Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hygiene 27 (1938) 493-497
24. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
25. Snijder E.J., and Meulenberg J.J. The molecular biology of arteriviruses. J. Gen. Virol. 79 (1998) 961-979
26. Snijder E.J., and Meulenberg J.M. Arteriviruses. Fields Virology. 4th ed. (2001), Lippincott-Raven, Philadelphia
27. Stadejek T., Björklund H., Bascuñana C.R., Ciabatti I.M., Scicluna M.T., Amaddeo D., McCollum W.H., Autorino G.L., Timoney P.J., Paton D.J., Klingeborn B., and Belák S. Genetic diversity of equine arteritis virus. J. Gen. Virol. 80 (1999) 691-699
28. ter Brake O., t'Hooft K., Liu Y.P., Centlivre M., von Eije K.J., and Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol. Ther. 16 (2008) 557-564
29. van den Born E., Stein D.A., Iversen P.L., and Snijder E.J. Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture. J. Gen. Virol. 86 (2005) 3081-3090
30. van Dinten L.C., den Boon J.A., Wassenaar A.L., Spaan W.J., and Snijder E.J. An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 991-996
31. Voinnet O. RNA silencing as a plant immune system against viruses. Trends Genet. 17 (2001) 449-459
32. Westerhout E.M., and Berkhout B. A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res. 35 (2007) 4322-4330
33. Wilkins C., Dishongh R., Moore S.C., Whitt M.A., Chow M., and Machaca K. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 436 (2005) 1044-1047